We are live on ! Find out more
ASMB icon

Assembly Biosciences

72 hedge funds and large institutions have $432M invested in Assembly Biosciences in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

67% more capital invested

Capital invested by funds: $259M → $432M (+$173M)

14% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 22

11% more funds holding

Funds holding: 6572 (+7)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.09% less ownership

Funds ownership: 6.03%5.94% (-0.09%)

50% less call options, than puts

Call options by funds: $1.84M | Put options by funds: $3.7M

Holders
72
Holders Change
+7
Holders Change %
+10.77%
% of All Funds
1.8%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
25
Reduced
22
Closed
5
Calls
$1.84M
Puts
$3.7M
Net Calls
-$1.86M
Net Calls Change
-$5.93M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.33M +$285K +930 +42%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$1.24M -$256K -835 -22%
Invesco
28
Invesco
Georgia
$1.02M -$889K -2,900 -54%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$975K +$86.4K +282 +14%
Acadian Asset Management
30
Acadian Asset Management
Massachusetts
$965K +$288K +941 +69%
Wells Fargo
31
Wells Fargo
California
$894K +$391K +1,275 +149%
TA
32
Teachers Advisors
New York
$871K
Charles Schwab
33
Charles Schwab
California
$818K
SO
34
STRS Ohio
Ohio
$792K +$233K +759 +67%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$784K -$60.4K -197 -10%
Victory Capital Management
36
Victory Capital Management
Texas
$764K -$16.2K -53 -3%
PP
37
PDT Partners
New York
$752K +$550K +1,794 New
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$684K -$590K -1,924 -54%
Two Sigma Investments
39
Two Sigma Investments
New York
$598K +$117K +382 +37%
Mackenzie Financial
40
Mackenzie Financial
Ontario, Canada
$577K +$422K +1,377 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$524K
Federated Hermes
42
Federated Hermes
Pennsylvania
$523K +$370K +1,206 +2,871%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$522K +$4.6K +15 +1%
JGGDR
44
JGP Global Gestao de Recursos
Brazil
$510K +$373K +1,216 New
AQR Capital Management
45
AQR Capital Management
Connecticut
$487K +$356K +1,162 New
EI
46
EAM Investors
California
$474K -$105K -342 -23%
Goldman Sachs
47
Goldman Sachs
New York
$404K -$829K -2,704 -74%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$385K -$4.29K -14 -2%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$384K
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$381K

ASMB Hedge Fund Activity: Q3 2017 in Review

72 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2017, worth a combined $432M — up 67% from $259M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ASMB positions and 5 closed out — a net gain of 8 holders — while 25 added to existing stakes and 22 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $7.66M. The largest seller was QVT Financial, cutting an estimated $8.66M.

  • 72 institutional investors held Assembly Biosciences (ASMB) as of Q3 2017, up from 65 in Q2 2017.
  • Funds reported $432M of Assembly Biosciences stock for Q3 2017, up 67% quarter-over-quarter.
  • 13 funds opened new Assembly Biosciences positions in Q3 2017 and 5 closed out, a net change of +8 holders.
  • The largest Assembly Biosciences buyer in Q3 2017 was Avoro Capital Advisors, an estimated $7.66M added.
  • The largest Assembly Biosciences seller in Q3 2017 was QVT Financial, an estimated $8.66M sold.

Based on aggregated 13F filings for Q3 2017.